Each 10 ml vial of EU Equipoise 300 contains 300 mg/ml Boldenone Undecylenate (commonly known as Equipoise). This long-chain ester is studied for its extended release profile and sustained anabolic-androgenic signaling in controlled laboratory models.

Composition per 1 ml

• 300 mg Boldenone Undecylenate (USP-grade reference)
• 20 % Benzyl Benzoate (USP)
• 2 % Benzyl Alcohol (USP)
• Ethyl Oleate (carrier solvent)

Note: This formulation contains Ethyl Oleate.

Research Context

Boldenone Undecylenate is referenced in literature for its long-duration pharmacokinetics and stable anabolic activity over extended observation periods. Researchers employ it to examine:

• Long-acting ester metabolism and clearance rates.
• Nitrogen-balance and protein-synthesis pathways.
• Receptor occupancy and comparative anabolic index.
• Interactions between carbon-chain length and release kinetics.

Formulation Characteristics

Ethyl Oleate serves as a smooth, low-viscosity carrier that maintains ester stability and uniform suspension. This enables consistent sampling and ease of laboratory manipulation using standard fine-gauge instrumentation.

Package Contents

• 1 × 10 ml vial of EU Equipoise 300 (300 mg/ml Boldenone Undecylenate)
• Ancillary not included.

Quality Assurance

EU Pharmaceuticals manufactures all reference solutions under controlled conditions with rigorous purity verification and batch-specific traceability. Each vial is labeled for laboratory identification and research documentation.

For laboratory, educational, and research use only. Not for human or veterinary ingestion, diagnostic, or therapeutic purposes. No medical or performance claims are made or implied. Buyer is responsible for lawful acquisition, handling, and compliance with all applicable regulations.